SCHEMBL1661671

SCHEMBL1661671

CN1CC(O)(C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21791083 0.82 OPRM1 (0.36)
SCHEMBL19080638 0.78 LMNA (0.36)
SCHEMBL26409832 0.74 CYP1A2 (0.37)
SCHEMBL12128892 0.72
SCHEMBL1661667 0.72
SCHEMBL18220604 0.72
SCHEMBL24004511 0.72 CRHBP (0.38)
SCHEMBL19090799 0.72 SMN1; SMN2 (0.37)
Hydrochloric Acid SCHEMBL11847606 0.72 OPRM1 (0.37)
SCHEMBL11565850 0.72 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3831824-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-06-09 EP disclosed
WO-2020024997-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 WO disclosed
WO-2020025030-A1 PREPARATION AND APPLICATION OF AROMATIC COMPOUND HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 WO disclosed
EP-2569324-B9 AMINOGLYCOSIDE DERIVATIVES REMPEX PHARMACEUTICALS INC (US) 2018-03-28 EP disclosed
EP-2569324-B1 AMINOGLYCOSIDE DERIVATIVES REMPEX PHARMACEUTICALS INC (US) 2017-12-06 EP disclosed
US-20170190729-A1 POLYENE MACROLIDE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2017-07-06 US disclosed
EP-2306994-B1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC (US) 2013-08-14 EP disclosed
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP disclosed
US-7842685-B2 S1P1 receptor agonists and use thereof AMGEN INC. (US) 2010-11-30 US disclosed
US-20100029611-A1 S1P1 receptor agonists and use thereof AMGEN INC. (US) 2010-02-04 US disclosed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed
WO-2008124821-A1 ANTIBACTERIAL 1,4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS ACHAOGEN INC. (US) 2008-10-16 WO disclosed
EP-0001280-B1 1-N-ACYLATED-4-O-GLYCOSYL-6-O-GLYCOSYL-1,3-DIAMINOCYCLITOL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SHIONOGI & CO., LTD. (JP) 1981-11-25 EP disclosed
US-4199570-A AZETIDINE, PYRROLIDINE, OR PIPERIDINE SHIONOGI & CO., LTD. (JP) 1980-04-22 US disclosed
EP-0001280-A2 1-N-acylated-4-O-glycosyl-6-O-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them SHIONOGI & CO., LTD. (JP) 1979-04-04 EP disclosed